Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / ATNM - Actinium Astellas in research pact for radiotherapies


ATNM - Actinium Astellas in research pact for radiotherapies

Actinium Pharmaceuticals (ATNM) has announced a research collaboration with Astellas Pharma (ALPMF) for the development of targeted radiotherapies using its Antibody Warhead Enabling ((AWE)) technology platform.Under this agreement, Actinium will utilize its AWE Platform technology to develop and characterize selected Astellas targeting agents labeled with the potent alpha-emitting radioisotope Actinium-225 (Ac-225).Actinium shares are up 2% in premarket

For further details see:

Actinium, Astellas in research pact for radiotherapies
Stock Information

Company Name: Actinium Pharmaceuticals Inc.
Stock Symbol: ATNM
Market: NYSE
Website: actiniumpharma.com

Menu

ATNM ATNM Quote ATNM Short ATNM News ATNM Articles ATNM Message Board
Get ATNM Alerts

News, Short Squeeze, Breakout and More Instantly...